The Applicability of a Checklist for the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency: Results of the Italian Exocrine Pancreatic Insufficiency Registry

Published on Jul 1, 2020in Pancreas2.92
· DOI :10.1097/MPA.0000000000001575
Raffaele Pezzilli56
Estimated H-index: 56
Gabriele Capurso54
Estimated H-index: 54
+ 7 AuthorsAlessandro Zerbi57
Estimated H-index: 57
OBJECTIVE To evaluate a rapid checklist capable of identifying exocrine pancreatic insufficiency in outpatients. METHODS Prospective observational study of a multicenter cohort. RESULTS One hundred and two patients were enrolled; 61.8% of the patients had medically-treated benign or malignant pancreatic disease, and 38.2% had a pancreatic resection. Visual examination of the feces was evaluated in 84 patients and it was related to steatorrhea in 51 patients (50.0%). Receiver operating characteristic curves were evaluated for each symptom or clinical sign and four of them (ie, increase in daily bowel movements, number of bowel movements, fatty stools, >10% weight loss) had a satisfactory area under the curve. At multivariate analysis, fatty stools and >10% weight loss entered into this analysis having an area under the curve of 0.916 (95% confidence interval, 0.851-0.981). At 1 month and at one year of follow-up, the pancreatic enzyme replacement therapy administered showed that pancreatic extracts were able to significantly improve the increase in daily bowel movements, the number of bowel movements, fatty and bulky stools and >10% weight loss. CONCLUSION Both fatty stools and >10% weight loss were able to clinically evaluate steatorrhea, and their improvement was sufficient to evaluate substitution therapy.
📖 Papers frequently viewed together
3 Citations
14 Authors (Jan G. D'Haese, ..., Helmut Friess)
37 Citations
#1Raffaele PezzilliH-Index: 56
Last. Massimo FalconiH-Index: 107
view all 6 authors...
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global cancer deaths in industrialised countries. More than 80% of patients suffer from significant weight loss at diagnosis and over time tend to develop severe cachexia. A major cause of weight loss is malnutrition. Patients may experience pancreatic exocrine insufficiency (PEI) before diagnosis, during nonsurgical treatment, and/or following surgery. PEI is difficult to diagnose because testing is cumbersome. Conse...
8 CitationsSource
#1Wei Huang (Sichuan University)H-Index: 24
Last. Robert Sutton (University of Liverpool)H-Index: 58
view all 16 authors...
Background/Objectives The epidemiology of exocrine pancreatic insufficiency (EPI) after acute pancreatitis (AP) is uncertain. We sought to determine the prevalence, progression, etiology and pancreatic enzyme replacement therapy (PERT) requirements for EPI during follow-up of AP by systematic review and meta-analysis.
14 CitationsSource
#1Colin D. Johnson (University Hospital Southampton NHS Foundation Trust)H-Index: 53
#2Nicola Williamson (Adelphi University)H-Index: 3
Last. Markus M. LerchH-Index: 101
view all 11 authors...
Abstract Background/objectives Pancreatic exocrine insufficiency (PEI) is commonly caused by chronic pancreatitis (CP) or cystic fibrosis (CF). There are no PEI-specific patient-reported assessments of symptoms and impacts. The PEI Questionnaire (PEI-Q) was developed through qualitative research with PEI patients and expert clinical input. This study evaluated the psychometric properties of the PEI-Q. Methods 162 PEI patients (CF = 71 and CP = 91), 62 diarrhoea-specific irritable bowel syndrome ...
11 CitationsSource
#1Filippo AntoniniH-Index: 9
#2Stefano CrippaH-Index: 60
Last. Raffaele PezzilliH-Index: 56
view all 5 authors...
Abstract Exocrine pancreatic insufficiency (EPI) is one of the possible mechanisms of fat maldigestion following gastric surgery, together with reduced food intake, loss of gastric reservoir, small bowel bacterial overgrowth and rapid small bowel transit. Oral pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment for EPI. The efficacy and safety of pancreatic enzyme substitution in patients following gastric resection remains unclear. This review article summarizes relevant s...
10 CitationsSource
#1Colin D. Johnson (University Hospital Southampton NHS Foundation Trust)H-Index: 53
#2Rob Arbuckle (Adelphi University)H-Index: 9
Last. Markus M. LerchH-Index: 101
view all 9 authors...
Background Pancreatic exocrine insufficiency (PEI) affects patients with chronic pancreatitis (CP) and cystic fibrosis (CF) who produce insufficient digestive pancreatic enzymes. Common symptoms include steatorrhoea, diarrhea, and abdominal pain.
14 CitationsSource
#1Luis SabaterH-Index: 22
#2Fabio Ausania (University of Vigo)H-Index: 4
Last. Enrique de-MadariaH-Index: 18
view all 26 authors...
Objective:To provide evidence-based recommendations for the management of exocrine pancreatic insufficiency (EPI) after pancreatic surgery.Background:EPI is a common complication after pancreatic surgery but there is certain confusion about its frequency, optimal methods of diagnosis, and when and h
42 CitationsSource
Exocrine pancreatic insufficiency coverage (EPIc) is an educational project for gastroenterologists, which is supported by the Italian Association for the Study of the Pancreas to disseminate knowledge regarding severe exocrine pancreatic insufficiency (EPI). The aim of this study was to produce a rapid checklist capable of identifying EPI in outpatients and evaluating whether the educational project is able to modify the clinical practice of participant gastroenterologists.Seven pancreatologist...
5 Citations
#1Björn Lindkvist (University of Gothenburg)H-Index: 51
#2Mary Phillips (Royal Surrey County Hospital)H-Index: 7
view all 3 authors...
Pancreatic exocrine insufficiency (PEI) frequently occurs secondary to exocrine pancreatic disease (e.g. chronic pancreatitis, cystic fibrosis, cancer) or pancreatic/gastrointestinal surgery, resulting in the maldigestion of nutrients and consequently malnutrition. Pancreatic enzyme replacement therapy (PERT) is the cornerstone of PEI management. Despite its clinical relevance, the diagnosis of PEI in clinical practice is challenging, as the current gold standard test is cumbersome, and alternat...
52 CitationsSource
#1Raffaele Pezzilli (University of Milan)H-Index: 56
Last. Alessandra BarassiH-Index: 21
view all 3 authors...
There are no studies comparing some of the most important markers, such as vitamin D, parathormone, osteocalcin, bone alkaline phosphatase, and calcium, in patients with chronic benign and malignant pancreatic diseases. Our objective was to comparatively evaluate serum markers of bone metabolism in patients with chronic pancreatitis and in those with ductal pancreatic adenocarcinoma. Sixty-three consecutive subjects were studied: 30 patients with a firm diagnosis of chronic pancreatitis and 33 h...
8 CitationsSource
UNLABELLED: There are numerous studies in the literature regarding the involvement of intestinal as well as extra intestinal organs during the course of celiac disease, and there is accumulating evidence regarding the pancreatic changes caused by this pathology. METHOD: The literature on the relationship between celiac disease and pancreatic involvement has been extensively reviewed. RESULTS: Exocrine pancreatic involvement regards both the function and the morphology of the exocrine pancreas, a...
4 CitationsSource
Cited By1
#2Cristina Jiménez-Luna (UGR: University of Granada)H-Index: 8
Last. Octavio Caba (UGR: University of Granada)H-Index: 16
view all 5 authors...
Exocrine pancreatic insufficiency (EPI) is defined as the maldigestion of foods due to inadequate pancreatic secretion, which can be caused by alterations in its stimulation, production, transport, or interaction with nutrients at duodenal level. The most frequent causes are chronic pancreatitis in adults and cystic fibrosis in children. The prevalence of EPI is high, varying according to its etiology, but it is considered to be underdiagnosed and undertreated. Its importance lies in the quality...